edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
BiomX (NYSE: PHGE) is a microbiome company developing customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and colorectal cancer (CRC), as well as bacteria that affect the appearance of the skin. Phage is a form of virus which attacks only bacteria. BiomX discovers and validates proprietary bacterial targets and customizes its natural and engineered phage compositions against these targets.
In our Israel office, EdisonTV interviews BiomX chief executive officer, Jonathan Solomon, providing us with an introduction to the company and an update on its progress.
Get access to the very latest content matched to your personal investment style.